FindTrial
Sign In

Study of Patient/tumor/treatment related factors (Anemia, weight loss, muscle strength ect) on treatment toxicities and post treatment outcome

To assess the impact of patient-specific, tumor and treatment related factors on treatment toxicities and oncological outcome in head and neck cancer patients receiving definitive radiotherapy or chemo-radiotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/11/038031
Enrollment
182
Registered
2021-11-15
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C01- Malignant neoplasm of base of tongue Health Condition 2: C021- Malignant neoplasm of border of tongue Health Condition 3: C060- Malignant neoplasm of cheek mucosa Health Condition 4: C020- Malignant neoplasm of dorsal surface of tongue Health Condition 5: C049- Malignant neoplasm of floor of mouth, unspecified Health Condition 6: C031- Malignant neoplasm of lower gum Health Condition 7: C119- Malignant neoplasm of nasopharynx,unspecified Health Condition 8: C109-

Interventions

None listed

Sponsors

JIPMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Newly diagnosed squamous cell carcinoma patients of head and neck (Oral cavity, Nasopharynx, Oropharynx, Larynx and Hypopharynx), treatment naïve planned for definitive radiotherapy or chemoradiotherapy 2.Age â?? Above 18 years

Exclusion criteria

Exclusion criteria: 1.Head and Neck cancer patients with Distant metastasis 2.Patients with active viral infection- HIV, Hepatitis B/C, COVID-19, active tubercular infection, any other active bacterial infection 3.Patients with abnormal liver or renal function tests 4.Patients with conditions â?? uncontrolled DM/HTN, Walking impairment, History of autoimmune disease

Design outcomes

Primary

MeasureTime frame
To assess the impact of patient specific, tumor and treatment related factors on treatment related acute toxicities (Grade wise) â?? as per RTOG Criteria (skin, mucosal, pharyngeal, laryngeal), as per CTCAE Criteria version 5 (hematological and gastrointestinal)Timepoint: After the completion of 6 weeks of proposed Cancer treatment—

Secondary

MeasureTime frame
To assess the impact of patient specific, tumor and treatment related factors on oncological outcome in head and neck cancer patients receiving definitive radiotherapy or chemo-radiotherapyTimepoint: After the completion of 6 weeks of proposed Cancer treatment—

Countries

India

Contacts

Public ContactDr Pooja Sethi

JIPMER

docpujasethi@gmail.com9543601257

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026